Evidence map›Paper›PMID 28638864›Full record

ArticleAfrican journal of traditional, complementary, and alternative medicines : AJTCAM2017

PROTECTIVE EFFECT OF VANILLIC ACID ON OVARIECTOMY-INDUCED OSTEOPOROSIS IN RATS.

Yong Gui Wang, Liang Bo Jiang, Bo Gou

Open access · diamondAbstract read
In one paragraph

Article in African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Bone Health and Natural Products- An Insight.Frontiers in pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yong Gui WangDepartment of Orthopaedics, Xiangyang No.1 People's Hospital affiliated to Hubei University of Medicine, Xiangyang, Hubei 441000, China.
Liang Bo JiangDepartment of Microscopic Orthopaedics, Shiyan People's Hospital affiliated to Hubei University of Medicine, Shiyan, Hubei 442000, China.
Bo GouDepartment of Orthopaedics, Shiyan People's Hospital affiliated to Hubei University of Medicine, Shiyan, Hubei 442000, China.
Hubei University of Medicine · CNPeople's Hospital of Shiyan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe need for an anti-osteoporotic agent is in high demand since osteoporosis contributes to high rates of disability or impairment (high osteoporotic fracture), morbidity and mortality. Hence, the present study is designed to evaluate the protective effects of vanillic acid (VA) against bilateral ovariectomy-induced osteoporosis in female Sprague-Dawley (SD) rats. MATERIALS AND

methodsForty healthy female adult SD rats were separated in to four groups with sham-operated control with bilateral laprotomy (Sham;

resultsA significant change in the body weight gain was noted in OVX group, while treatment with VA substantially reverted to normalcy. Meanwhile, the bone mineral density and content (BMD and BMC) were substantially improved on supplementation with VA. Also, the bone turnover markers like calcium (Ca), phosphorous (P), osteocalcin (OC), alkaline phosphatase (ALP) and deoxypyridinoline (DPD) and inflammatory markers (IL-1β, IL-6, and TNF-α) levels were markedly attenuated in VA-treated rats. Moreover, the biomechanical stability was greatly ameliorated with VA administration. Both the dose of VA showed potent anti-osteoporotic activity, but VA 100 mg showed highest protective effects as compared with 50 mg of VA.

conclusionBased on the outcome, we concluded that VA 100 showed better anti-osteoporotic activity by improving BMD and BMC as well as biomechanical stability and therefore used as an alternative therapy for treating postmenopausal osteoporosis.

Indexed as

AnimalsBone DensityFemaleHumansInterleukin-6Osteoporosis, PostmenopausalOvariectomyRatsRats, Sprague-DawleyTumor Necrosis Factor-alphaVanillic AcidInterleukin-6Tumor Necrosis Factor-alphaVanillic AcidAntioxidantInflammatory markersOsteoporosisOvariectomyVanillic acid

Identifiers

PMID28638864
PMCPMC5471479
OpenAlexW2624198030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.